Although serum VEGF and TSP-1 are the most studied pro- and antiangiogenic factors, respectively, and highly elevated in angiogenesis-related diseases, studies regarding platelet-derived VEGF and TSP-1 are scarce in lung cancer patients. Here, VEGFA is linked to lung cancer.